DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice
We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in vitro by suppressing the Wnt/β-catenin signaling pathway. However, it remained unexplored whether DIF-1 also inhibits tumor growth in vivo. In t...
Saved in:
Published in | Biochemical pharmacology Vol. 89; no. 3; pp. 340 - 348 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.06.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in vitro by suppressing the Wnt/β-catenin signaling pathway. However, it remained unexplored whether DIF-1 also inhibits tumor growth in vivo. In the present study, therefore, we examined in-vivo effects of DIF-1 using three cancer models: Mutyh-deficient mice with oxidative stress-induced intestinal tumors and nude mice xenografted with the human colon cancer cell line HCT-116 and cervical cancer cell line HeLa. In exploration for an appropriate route of administration, we found that orally administered DIF-1 was absorbed through the digestive tract to elevate its blood concentration to levels enough to suppress tumor cell proliferation. Repeated oral administration of DIF-1 markedly reduced the number and size of intestinal tumors that developed in Mutyh-deficient mice, reducing the phosphorylation level of GSK-3β Ser9 and the expression levels of early growth response-1 (Egr-1), transcription factor 7-like 2 (TCF7L2) and cyclin D1. DIF-1 also inhibited the growth of HCT-116- and HeLa-xenograft tumors together with decreasing phosphorylation level of GSK-3β Ser9, although it was not statistically significant in HeLa-xenograft tumors. DIF-1 also suppressed the expressions of Egr-1, TCF7L2 and cyclin D1 in HCT-116-xenograft tumors and those of β-catenin, TCF7L2 and cyclin D1 in HeLa-xenograft tumors. This is the first report to show that DIF-1 inhibits tumor growth in vivo, consistent with its in-vitro action, suggesting that this compound may have potential as a novel anti-tumor agent. |
---|---|
AbstractList | We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in vitro by suppressing the Wnt/β-catenin signaling pathway. However, it remained unexplored whether DIF-1 also inhibits tumor growth in vivo. In the present study, therefore, we examined in-vivo effects of DIF-1 using three cancer models: Mutyh-deficient mice with oxidative stress-induced intestinal tumors and nude mice xenografted with the human colon cancer cell line HCT-116 and cervical cancer cell line HeLa. In exploration for an appropriate route of administration, we found that orally administered DIF-1 was absorbed through the digestive tract to elevate its blood concentration to levels enough to suppress tumor cell proliferation. Repeated oral administration of DIF-1 markedly reduced the number and size of intestinal tumors that developed in Mutyh-deficient mice, reducing the phosphorylation level of GSK-3β Ser(9) and the expression levels of early growth response-1 (Egr-1), transcription factor 7-like 2 (TCF7L2) and cyclin D1. DIF-1 also inhibited the growth of HCT-116- and HeLa-xenograft tumors together with decreasing phosphorylation level of GSK-3β Ser(9), although it was not statistically significant in HeLa-xenograft tumors. DIF-1 also suppressed the expressions of Egr-1, TCF7L2 and cyclin D1 in HCT-116-xenograft tumors and those of β-catenin, TCF7L2 and cyclin D1 in HeLa-xenograft tumors. This is the first report to show that DIF-1 inhibits tumor growth in vivo, consistent with its in-vitro action, suggesting that this compound may have potential as a novel anti-tumor agent. We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in vitro by suppressing the Wnt/β-catenin signaling pathway. However, it remained unexplored whether DIF-1 also inhibits tumor growth in vivo. In the present study, therefore, we examined in-vivo effects of DIF-1 using three cancer models: Mutyh-deficient mice with oxidative stress-induced intestinal tumors and nude mice xenografted with the human colon cancer cell line HCT-116 and cervical cancer cell line HeLa. In exploration for an appropriate route of administration, we found that orally administered DIF-1 was absorbed through the digestive tract to elevate its blood concentration to levels enough to suppress tumor cell proliferation. Repeated oral administration of DIF-1 markedly reduced the number and size of intestinal tumors that developed in Mutyh-deficient mice, reducing the phosphorylation level of GSK-3β Ser9 and the expression levels of early growth response-1 (Egr-1), transcription factor 7-like 2 (TCF7L2) and cyclin D1. DIF-1 also inhibited the growth of HCT-116- and HeLa-xenograft tumors together with decreasing phosphorylation level of GSK-3β Ser9, although it was not statistically significant in HeLa-xenograft tumors. DIF-1 also suppressed the expressions of Egr-1, TCF7L2 and cyclin D1 in HCT-116-xenograft tumors and those of β-catenin, TCF7L2 and cyclin D1 in HeLa-xenograft tumors. This is the first report to show that DIF-1 inhibits tumor growth in vivo, consistent with its in-vitro action, suggesting that this compound may have potential as a novel anti-tumor agent. |
Author | Jingushi, Kentaro Igawa, Kazuhiro Takahashi-Yanaga, Fumi Morimoto, Sachio Watanabe, Yutaka Sasaguri, Toshiyuki Tomooka, Katsuhiko Tsuzuki, Teruhisa Nakabeppu, Yusaku Yoshihara, Tatsuya Nakatsu, Yoshimichi |
Author_xml | – sequence: 1 givenname: Fumi surname: Takahashi-Yanaga fullname: Takahashi-Yanaga, Fumi email: yanaga@cliphrarm.med.kyushu-u.ac.jp organization: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 2 givenname: Tatsuya surname: Yoshihara fullname: Yoshihara, Tatsuya organization: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 3 givenname: Kentaro surname: Jingushi fullname: Jingushi, Kentaro organization: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 4 givenname: Kazuhiro surname: Igawa fullname: Igawa, Kazuhiro organization: Department of Molecular and Material Science, Institute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan – sequence: 5 givenname: Katsuhiko surname: Tomooka fullname: Tomooka, Katsuhiko organization: Department of Molecular and Material Science, Institute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan – sequence: 6 givenname: Yutaka surname: Watanabe fullname: Watanabe, Yutaka organization: Department of Applied Chemistry, Faculty of Engineering, Ehime University, Matsuyama, Japan – sequence: 7 givenname: Sachio surname: Morimoto fullname: Morimoto, Sachio organization: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 8 givenname: Yoshimichi surname: Nakatsu fullname: Nakatsu, Yoshimichi organization: Department of Medical Biophysics and Radiation Biology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 9 givenname: Teruhisa surname: Tsuzuki fullname: Tsuzuki, Teruhisa organization: Department of Medical Biophysics and Radiation Biology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan – sequence: 10 givenname: Yusaku surname: Nakabeppu fullname: Nakabeppu, Yusaku organization: Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan – sequence: 11 givenname: Toshiyuki surname: Sasaguri fullname: Sasaguri, Toshiyuki email: sasaguri@cliphrarm.med.kyushu-u.ac.jp organization: Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24670930$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kM9O3DAQxq2KChbKA_RS-dhLUv9JnEQ9oYWliJU4QM-WY09Yr5I42MnC3nmiPkifqU4Xeuxh5Jn5vvkk_07RUe96QOgzJSklVHzbprUeUkZolhKeEiI-oAUtC56wSpRHaEHiKvY5O0GnIWznsRT0GJ2wTBSk4mSBXi9vVgnFtt_Y2o4Bj1PnPH707nncxC3e2Z3DHsykbf-Ih40Lsfy-VaN1PXYNvr6_TfjvX1j1BsPL4CGEqIRZ0nvdxohL-ld8WK6KNZszteo1eNw5Ay3urIZP6GOj2gDnb-8Z-rm6elj-SNZ31zfLi3Wiec7HhHPNmspUwIuaCM4UyxvKWKUrXihR16UxShOjQVSCl0RlOupAIoyKmYJn_Ax9PeQO3j1NEEbZ2aChbVUPbgqS5ozyaM_yaKUHq_YuBA-NHLztlN9LSuQMX25lhC9n-JJwGdHGmy9v8VPdgfl38U47Gr4fDBA_ubPgZdAWIgxjPehRGmf_E_8HxXCWVg |
CitedBy_id | crossref_primary_10_1038_s41388_021_01958_4 crossref_primary_10_18632_oncotarget_8319 crossref_primary_10_1016_j_intimp_2023_109913 crossref_primary_10_3390_ijms25031889 crossref_primary_10_1111_cas_13106 crossref_primary_10_1002_bab_2258 crossref_primary_10_1016_j_lfs_2024_122807 crossref_primary_10_1158_0008_5472_CAN_19_0438 crossref_primary_10_3389_fcell_2021_758317 crossref_primary_10_1038_srep34284 crossref_primary_10_1248_bpb_b21_01046 crossref_primary_10_1016_j_bbrc_2015_01_048 crossref_primary_10_3390_ijms150712543 crossref_primary_10_1016_j_bbrc_2016_05_066 crossref_primary_10_1016_j_bbamcr_2020_118909 crossref_primary_10_1016_j_lfs_2023_122278 crossref_primary_10_1016_j_jphs_2023_02_009 crossref_primary_10_1111_cas_14204 crossref_primary_10_1007_s11655_022_3590_z crossref_primary_10_1016_j_biomaterials_2020_120198 crossref_primary_10_1016_j_bcp_2017_05_004 crossref_primary_10_1016_j_bcp_2023_115663 crossref_primary_10_1016_j_bbrc_2019_09_117 crossref_primary_10_1016_j_jphs_2015_03_005 crossref_primary_10_18632_oncotarget_14621 crossref_primary_10_1002_adfm_201502868 crossref_primary_10_3390_molecules28237926 |
Cites_doi | 10.1038/sj.onc.1210059 10.1042/bj2490903 10.1101/gad.12.22.3499 10.1016/j.yexcr.2005.07.024 10.1038/328811a0 10.1210/en.2004-0959 10.1126/science.1094291 10.1093/nar/28.6.1355 10.1038/73448 10.1038/35096075 10.1042/bj2560023 10.1016/S1359-6101(00)00011-3 10.1042/bj3590001 10.1016/j.bbrc.2005.10.018 10.1016/j.bbrc.2008.10.115 10.1016/S0140-6736(03)13805-6 10.1016/S0021-9258(19)67786-0 10.1158/0008-5472.CAN-03-3551 10.1254/jphs.09348FP 10.1038/nrc2231 10.1074/jbc.M205768200 10.1056/NEJMoa025283 10.1126/science.274.5293.1672 10.1038/sj.onc.1202746 10.1186/1476-4598-9-245 10.1016/j.cellsig.2007.10.018 10.1359/jbmr.060512 10.1074/jbc.M605205200 10.1146/annurev.cellbio.20.010403.113126 10.1038/ncpgasthep0473 10.1073/pnas.96.23.13300 10.1074/jbc.C300316200 10.1016/j.bcp.2011.10.001 10.1158/0008-5472.CAN-06-4802 10.1056/NEJM200006293422603 10.1038/ng828 10.1126/science.1071549 10.1023/A:1006103831990 10.1016/j.bcp.2006.12.033 10.1126/science.275.5307.1787 10.1159/000055379 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.bcp.2014.03.006 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2968 |
EndPage | 348 |
ExternalDocumentID | 10_1016_j_bcp_2014_03_006 24670930 S0006295214001786 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABLJU ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACNCT ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IH2 IHE J1W K-O KOM L7B M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SDP SES SPCBC SPT SSP SSZ T5K TEORI TWZ WH7 ZA5 ~G- AAXKI AKRWK CGR CUY CVF ECM EIF NPM .55 .GJ .HR 3O- 53G AAQXK AAYJJ AAYXX ADMUD AFFNX AFJKZ AHHHB AI. ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMT HVGLF HZ~ LPU R2- SEW VH1 WUQ X7M ZGI ZXP 7X8 |
ID | FETCH-LOGICAL-c353t-33c2f9d9e37b0632a25f1229c937a6bb8ddac0dce696380a4c5f1e029692d7343 |
IEDL.DBID | .~1 |
ISSN | 0006-2952 |
IngestDate | Wed Sep 11 08:37:37 EDT 2024 Thu Sep 26 16:27:13 EDT 2024 Sat Sep 28 08:02:43 EDT 2024 Fri Feb 23 02:26:16 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Egr-1 TCF7L2 GSK-3β Wnt/β-catenin signaling pathway DIF-1 |
Language | English |
License | Copyright © 2014 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c353t-33c2f9d9e37b0632a25f1229c937a6bb8ddac0dce696380a4c5f1e029692d7343 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24670930 |
PQID | 1521329645 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1521329645 crossref_primary_10_1016_j_bcp_2014_03_006 pubmed_primary_24670930 elsevier_sciencedirect_doi_10_1016_j_bcp_2014_03_006 |
PublicationCentury | 2000 |
PublicationDate | 2014-06-01 2014-Jun-01 2014-06-00 20140601 |
PublicationDateYYYYMMDD | 2014-06-01 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Biochemical pharmacology |
PublicationTitleAlternate | Biochem Pharmacol |
PublicationYear | 2014 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Yasmin, Takahashi-Yanaga, Mori, Miwa, Hirata, Watanabe (bib0110) 2005; 338 Frame, Cohen (bib0080) 2001; 359 Matsuda, Takahashi-Yanaga, Yoshihara, Maenaka, Watanabe, Miwa (bib0200) 2010; 112 Moon, Bowerman, Boutros, Perrimon (bib0010) 2002; 296 Takahashi-Yanaga, Taba, Miwa, Kubohara, Watanabe, Hirata (bib0105) 2003; 278 Shimizu, Murata, Tagawa, Takahashi, Ishikawa, Abe (bib0205) 2004; 64 Morin, Sparks, Korinek, Barker, Clevers, Vogelstein (bib0055) 1997; 275 Al-Tassan, Chmiel, Maynard, Fleming, Livingston, Williams (bib0140) 2002; 30 McDonald, Preston, Lovell, Wright, Jankowski (bib0065) 2006; 3 Nelson, Nusse (bib0005) 2004; 303 Sherr (bib0020) 1996; 274 Satoh, Daigo, Furukawa, Kato, Miwa, Nishiwaki (bib0060) 2000; 24 Akiyama (bib0015) 2000; 11 Sakamoto, Tominaga, Yamauchi, Nakatsu, Sakumi, Yoshiyama (bib0155) 2007; 67 Logan, Nusse (bib0050) 2004; 20 Jingushi, Takahashi-Yanaga, Yoshihara, Shiraishi, Watanabe, Hirata (bib0135) 2012; 83 Utsunomiya, Doki, Takemoto, Shiozaki, Yano, Sekimoto (bib0040) 2001; 61 Takahashi-Yanaga, Mori, Matsuzaki, Watanabe, Hirata, Miwa (bib0120) 2006; 281 Sakoguchi-Okada, Takahashi-Yanaga, Fukada, Shiraishi, Taba, Miwa (bib0190) 2007; 73 Steinbach, Lynch, Phillips, Wallace, Hawk, Gordon (bib0170) 2000; 342 Barnes, Gillett (bib0030) 1998; 52 Sampson, Dolwani, Jones, Eccles, Ellis, Evans (bib0145) 2003; 362 Segditsas, Tomlinson (bib0070) 2006; 25 Mori, Takahashi-Yanaga, Miwa, Watanabe, Hirata, Morimoto (bib0115) 2005; 310 Morris, Masento, Taylor, Jermyn, Kay (bib0100) 1988; 249 Diehl, Cheng, Roussel, Sherr (bib0085) 1998; 12 Masento, Morris, Taylor, Johnson, Skapski, Kay (bib0160) 1988; 256 Ohtsubo, Nishioka, Imaiso, Iwai, Shimokawa, Oda (bib0175) 2000; 28 Matsuzaki, Takahashi-Yanaga, Miwa, Hirata, Watanabe, Sato (bib0125) 2006; 21 Traynor, Kay (bib0165) 1991; 266 Fu, Wang, Li, Sakamaki, Pestell (bib0045) 2004; 145 Yoshihara, Takahashi-Yanaga, Shiraishi, Morimoto, Watanabe, Hirata (bib0130) 2010; 9 Takahashi-Yanaga, Sasaguri (bib0090) 2008; 20 Hirano, Tominaga, Ichinoe, Ushijima, Tsuchimoto, Honda-Ohnishi (bib0180) 2003; 278 Morris, Taylor, Masento, Jermyn, Kay (bib0095) 1987; 328 Takahashi-Yanaga, Yoshihara, Jingushi, Miwa, Morimoto, Hirata (bib0195) 2008; 377 Cohen, Frame (bib0075) 2001; 2 Klungland, Rosewell, Hollenbach, Larsen, Daly, Epe (bib0185) 1999; 96 Sieber, Lipton, Crabtree, Heinimann, Fidalgo, Phillips (bib0150) 2003; 348 Nesbit, Tersak, Prochownik (bib0035) 1999; 18 Meyer, Penn (bib0025) 2008; 8 Takahashi-Yanaga (10.1016/j.bcp.2014.03.006_bib0120) 2006; 281 Hirano (10.1016/j.bcp.2014.03.006_bib0180) 2003; 278 Nelson (10.1016/j.bcp.2014.03.006_bib0005) 2004; 303 Satoh (10.1016/j.bcp.2014.03.006_bib0060) 2000; 24 Yoshihara (10.1016/j.bcp.2014.03.006_bib0130) 2010; 9 Meyer (10.1016/j.bcp.2014.03.006_bib0025) 2008; 8 Jingushi (10.1016/j.bcp.2014.03.006_bib0135) 2012; 83 Al-Tassan (10.1016/j.bcp.2014.03.006_bib0140) 2002; 30 Morris (10.1016/j.bcp.2014.03.006_bib0095) 1987; 328 Takahashi-Yanaga (10.1016/j.bcp.2014.03.006_bib0090) 2008; 20 Segditsas (10.1016/j.bcp.2014.03.006_bib0070) 2006; 25 Sieber (10.1016/j.bcp.2014.03.006_bib0150) 2003; 348 Akiyama (10.1016/j.bcp.2014.03.006_bib0015) 2000; 11 Takahashi-Yanaga (10.1016/j.bcp.2014.03.006_bib0195) 2008; 377 Sakoguchi-Okada (10.1016/j.bcp.2014.03.006_bib0190) 2007; 73 Traynor (10.1016/j.bcp.2014.03.006_bib0165) 1991; 266 Ohtsubo (10.1016/j.bcp.2014.03.006_bib0175) 2000; 28 Mori (10.1016/j.bcp.2014.03.006_bib0115) 2005; 310 Fu (10.1016/j.bcp.2014.03.006_bib0045) 2004; 145 Frame (10.1016/j.bcp.2014.03.006_bib0080) 2001; 359 Nesbit (10.1016/j.bcp.2014.03.006_bib0035) 1999; 18 Yasmin (10.1016/j.bcp.2014.03.006_bib0110) 2005; 338 McDonald (10.1016/j.bcp.2014.03.006_bib0065) 2006; 3 Cohen (10.1016/j.bcp.2014.03.006_bib0075) 2001; 2 Klungland (10.1016/j.bcp.2014.03.006_bib0185) 1999; 96 Matsuda (10.1016/j.bcp.2014.03.006_bib0200) 2010; 112 Diehl (10.1016/j.bcp.2014.03.006_bib0085) 1998; 12 Morris (10.1016/j.bcp.2014.03.006_bib0100) 1988; 249 Steinbach (10.1016/j.bcp.2014.03.006_bib0170) 2000; 342 Morin (10.1016/j.bcp.2014.03.006_bib0055) 1997; 275 Utsunomiya (10.1016/j.bcp.2014.03.006_bib0040) 2001; 61 Takahashi-Yanaga (10.1016/j.bcp.2014.03.006_bib0105) 2003; 278 Sakamoto (10.1016/j.bcp.2014.03.006_bib0155) 2007; 67 Shimizu (10.1016/j.bcp.2014.03.006_bib0205) 2004; 64 Masento (10.1016/j.bcp.2014.03.006_bib0160) 1988; 256 Sampson (10.1016/j.bcp.2014.03.006_bib0145) 2003; 362 Logan (10.1016/j.bcp.2014.03.006_bib0050) 2004; 20 Moon (10.1016/j.bcp.2014.03.006_bib0010) 2002; 296 Barnes (10.1016/j.bcp.2014.03.006_bib0030) 1998; 52 Matsuzaki (10.1016/j.bcp.2014.03.006_bib0125) 2006; 21 Sherr (10.1016/j.bcp.2014.03.006_bib0020) 1996; 274 |
References_xml | – volume: 8 start-page: 976 year: 2008 end-page: 990 ident: bib0025 article-title: Reflecting on 25 years with MYC publication-title: Nat Rev Cancer contributor: fullname: Penn – volume: 275 start-page: 1787 year: 1997 end-page: 1790 ident: bib0055 article-title: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC publication-title: Science contributor: fullname: Vogelstein – volume: 61 start-page: 226 year: 2001 end-page: 233 ident: bib0040 article-title: Correlation of β-catenin and cyclin D1 expression in colon cancers publication-title: Oncology contributor: fullname: Sekimoto – volume: 12 start-page: 3499 year: 1998 end-page: 3511 ident: bib0085 article-title: Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization publication-title: Genes Dev contributor: fullname: Sherr – volume: 24 start-page: 245 year: 2000 end-page: 250 ident: bib0060 article-title: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 publication-title: Nat Genet contributor: fullname: Nishiwaki – volume: 52 start-page: 1 year: 1998 end-page: 15 ident: bib0030 article-title: Cyclin D1 in breast cancer publication-title: Breast Cancer Res Treat contributor: fullname: Gillett – volume: 3 start-page: 267 year: 2006 end-page: 274 ident: bib0065 article-title: Mechanisms of disease: from stem cells to colorectal cancer publication-title: Nat Clin Pract Gastroenterol Hepatol contributor: fullname: Jankowski – volume: 64 start-page: 2568 year: 2004 end-page: 2571 ident: bib0205 article-title: Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium publication-title: Cancer Res contributor: fullname: Abe – volume: 274 start-page: 1672 year: 1996 end-page: 1677 ident: bib0020 article-title: Cancer cell cycles publication-title: Science contributor: fullname: Sherr – volume: 249 start-page: 903 year: 1988 end-page: 906 ident: bib0100 article-title: Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould publication-title: Biochem J contributor: fullname: Kay – volume: 96 start-page: 13300 year: 1999 end-page: 13305 ident: bib0185 article-title: Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage publication-title: Proc Natl Acad Sci USA contributor: fullname: Epe – volume: 296 start-page: 1644 year: 2002 end-page: 1646 ident: bib0010 article-title: The promise and perils of Wnt signaling through β-catenin publication-title: Science contributor: fullname: Perrimon – volume: 21 start-page: 1307 year: 2006 end-page: 1316 ident: bib0125 article-title: Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines publication-title: J Bone Miner Res contributor: fullname: Sato – volume: 25 start-page: 7531 year: 2006 end-page: 7537 ident: bib0070 article-title: Colorectal cancer and genetic alterations in the Wnt pathway publication-title: Oncogene contributor: fullname: Tomlinson – volume: 145 start-page: 5439 year: 2004 end-page: 5447 ident: bib0045 article-title: Minireview Cyclin D1: normal and abnormal functions publication-title: Endocrinology contributor: fullname: Pestell – volume: 2 start-page: 769 year: 2001 end-page: 776 ident: bib0075 article-title: The renaissance of GSK3 publication-title: Nat Rev Mol Cell Biol contributor: fullname: Frame – volume: 359 start-page: 1 year: 2001 end-page: 16 ident: bib0080 article-title: GSK3 takes centre stage more than 20 years after its discovery publication-title: Biochem J contributor: fullname: Cohen – volume: 266 start-page: 5291 year: 1991 end-page: 5297 ident: bib0165 article-title: The DIF-1 signaling system in Dictyostelium. Metabolism of the signal publication-title: J Biol Chem contributor: fullname: Kay – volume: 18 start-page: 3004 year: 1999 end-page: 3016 ident: bib0035 article-title: MYC oncogenes and human neoplastic disease publication-title: Oncogene contributor: fullname: Prochownik – volume: 20 start-page: 781 year: 2004 end-page: 810 ident: bib0050 article-title: The Wnt signaling pathway in development and disease publication-title: Annu Rev Cell Dev Biol contributor: fullname: Nusse – volume: 338 start-page: 903 year: 2005 end-page: 909 ident: bib0110 article-title: Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells publication-title: Biochem Biophys Res Commun contributor: fullname: Watanabe – volume: 377 start-page: 1185 year: 2008 end-page: 1190 ident: bib0195 article-title: Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells publication-title: Biochem Biophys Res Commun contributor: fullname: Hirata – volume: 281 start-page: 38489 year: 2006 end-page: 38497 ident: bib0120 article-title: Involvement of GSK-3β and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells publication-title: J Biol Chem contributor: fullname: Miwa – volume: 9 start-page: 245 year: 2010 ident: bib0130 article-title: Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway publication-title: Mol Cancer contributor: fullname: Hirata – volume: 303 start-page: 1483 year: 2004 end-page: 1487 ident: bib0005 article-title: Convergence of Wnt, β-catenin, and cadherin pathways publication-title: Science contributor: fullname: Nusse – volume: 30 start-page: 227 year: 2002 end-page: 232 ident: bib0140 article-title: Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors publication-title: Nat Genet contributor: fullname: Williams – volume: 20 start-page: 581 year: 2008 end-page: 589 ident: bib0090 article-title: GSK-3β regulates cyclin D1 expression: a new target for chemotherapy publication-title: Cell Signal contributor: fullname: Sasaguri – volume: 83 start-page: 47 year: 2012 end-page: 56 ident: bib0135 article-title: DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines publication-title: Biochem Pharmacol contributor: fullname: Hirata – volume: 348 start-page: 791 year: 2003 end-page: 799 ident: bib0150 article-title: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH publication-title: N Engl J Med contributor: fullname: Phillips – volume: 256 start-page: 23 year: 1988 end-page: 28 ident: bib0160 article-title: Differentiation-inducing factor from the slime mould publication-title: Biochem J contributor: fullname: Kay – volume: 112 start-page: 320 year: 2010 end-page: 326 ident: bib0200 article-title: Dictyostelium differentiation-inducing factor-1 binds to mitochondrial malate dehydrogenase and inhibits its activity publication-title: J Pharmacol Sci contributor: fullname: Miwa – volume: 28 start-page: 1355 year: 2000 end-page: 1364 ident: bib0175 article-title: Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria publication-title: Nucleic Acids Res contributor: fullname: Oda – volume: 11 start-page: 273 year: 2000 end-page: 282 ident: bib0015 article-title: Wnt/β-catenin signaling publication-title: Cytokine Growth Factor Rev contributor: fullname: Akiyama – volume: 67 start-page: 6599 year: 2007 end-page: 6604 ident: bib0155 article-title: MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis publication-title: Cancer Res contributor: fullname: Yoshiyama – volume: 342 start-page: 1946 year: 2000 end-page: 1952 ident: bib0170 article-title: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis publication-title: N Engl J Med contributor: fullname: Gordon – volume: 310 start-page: 426 year: 2005 end-page: 433 ident: bib0115 article-title: Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr publication-title: Exp Cell Res contributor: fullname: Morimoto – volume: 73 start-page: 1318 year: 2007 end-page: 1329 ident: bib0190 article-title: Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells publication-title: Biochem Pharmacol contributor: fullname: Miwa – volume: 278 start-page: 9663 year: 2003 end-page: 9670 ident: bib0105 article-title: Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells publication-title: J Biol Chem contributor: fullname: Hirata – volume: 362 start-page: 39 year: 2003 end-page: 41 ident: bib0145 article-title: Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH publication-title: Lancet contributor: fullname: Evans – volume: 278 start-page: 38121 year: 2003 end-page: 38124 ident: bib0180 article-title: Mutator phenotype of MUTYH-null mouse embryonic stem cells publication-title: J Biol Chem contributor: fullname: Honda-Ohnishi – volume: 328 start-page: 811 year: 1987 end-page: 814 ident: bib0095 article-title: Chemical structure of the morphogen differentiation inducing factor from publication-title: Nature contributor: fullname: Kay – volume: 25 start-page: 7531 year: 2006 ident: 10.1016/j.bcp.2014.03.006_bib0070 article-title: Colorectal cancer and genetic alterations in the Wnt pathway publication-title: Oncogene doi: 10.1038/sj.onc.1210059 contributor: fullname: Segditsas – volume: 249 start-page: 903 year: 1988 ident: 10.1016/j.bcp.2014.03.006_bib0100 article-title: Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum publication-title: Biochem J doi: 10.1042/bj2490903 contributor: fullname: Morris – volume: 12 start-page: 3499 year: 1998 ident: 10.1016/j.bcp.2014.03.006_bib0085 article-title: Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization publication-title: Genes Dev doi: 10.1101/gad.12.22.3499 contributor: fullname: Diehl – volume: 310 start-page: 426 year: 2005 ident: 10.1016/j.bcp.2014.03.006_bib0115 article-title: Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2005.07.024 contributor: fullname: Mori – volume: 328 start-page: 811 year: 1987 ident: 10.1016/j.bcp.2014.03.006_bib0095 article-title: Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum publication-title: Nature doi: 10.1038/328811a0 contributor: fullname: Morris – volume: 145 start-page: 5439 year: 2004 ident: 10.1016/j.bcp.2014.03.006_bib0045 article-title: Minireview Cyclin D1: normal and abnormal functions publication-title: Endocrinology doi: 10.1210/en.2004-0959 contributor: fullname: Fu – volume: 303 start-page: 1483 year: 2004 ident: 10.1016/j.bcp.2014.03.006_bib0005 article-title: Convergence of Wnt, β-catenin, and cadherin pathways publication-title: Science doi: 10.1126/science.1094291 contributor: fullname: Nelson – volume: 28 start-page: 1355 year: 2000 ident: 10.1016/j.bcp.2014.03.006_bib0175 article-title: Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria publication-title: Nucleic Acids Res doi: 10.1093/nar/28.6.1355 contributor: fullname: Ohtsubo – volume: 24 start-page: 245 year: 2000 ident: 10.1016/j.bcp.2014.03.006_bib0060 article-title: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 publication-title: Nat Genet doi: 10.1038/73448 contributor: fullname: Satoh – volume: 2 start-page: 769 year: 2001 ident: 10.1016/j.bcp.2014.03.006_bib0075 article-title: The renaissance of GSK3 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/35096075 contributor: fullname: Cohen – volume: 256 start-page: 23 year: 1988 ident: 10.1016/j.bcp.2014.03.006_bib0160 article-title: Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues. Synthesis, structure and biological activity publication-title: Biochem J doi: 10.1042/bj2560023 contributor: fullname: Masento – volume: 11 start-page: 273 year: 2000 ident: 10.1016/j.bcp.2014.03.006_bib0015 article-title: Wnt/β-catenin signaling publication-title: Cytokine Growth Factor Rev doi: 10.1016/S1359-6101(00)00011-3 contributor: fullname: Akiyama – volume: 359 start-page: 1 year: 2001 ident: 10.1016/j.bcp.2014.03.006_bib0080 article-title: GSK3 takes centre stage more than 20 years after its discovery publication-title: Biochem J doi: 10.1042/bj3590001 contributor: fullname: Frame – volume: 338 start-page: 903 year: 2005 ident: 10.1016/j.bcp.2014.03.006_bib0110 article-title: Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.10.018 contributor: fullname: Yasmin – volume: 377 start-page: 1185 year: 2008 ident: 10.1016/j.bcp.2014.03.006_bib0195 article-title: Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2008.10.115 contributor: fullname: Takahashi-Yanaga – volume: 362 start-page: 39 year: 2003 ident: 10.1016/j.bcp.2014.03.006_bib0145 article-title: Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH publication-title: Lancet doi: 10.1016/S0140-6736(03)13805-6 contributor: fullname: Sampson – volume: 266 start-page: 5291 year: 1991 ident: 10.1016/j.bcp.2014.03.006_bib0165 article-title: The DIF-1 signaling system in Dictyostelium. Metabolism of the signal publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)67786-0 contributor: fullname: Traynor – volume: 64 start-page: 2568 year: 2004 ident: 10.1016/j.bcp.2014.03.006_bib0205 article-title: Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-3551 contributor: fullname: Shimizu – volume: 112 start-page: 320 year: 2010 ident: 10.1016/j.bcp.2014.03.006_bib0200 article-title: Dictyostelium differentiation-inducing factor-1 binds to mitochondrial malate dehydrogenase and inhibits its activity publication-title: J Pharmacol Sci doi: 10.1254/jphs.09348FP contributor: fullname: Matsuda – volume: 8 start-page: 976 year: 2008 ident: 10.1016/j.bcp.2014.03.006_bib0025 article-title: Reflecting on 25 years with MYC publication-title: Nat Rev Cancer doi: 10.1038/nrc2231 contributor: fullname: Meyer – volume: 278 start-page: 9663 year: 2003 ident: 10.1016/j.bcp.2014.03.006_bib0105 article-title: Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells publication-title: J Biol Chem doi: 10.1074/jbc.M205768200 contributor: fullname: Takahashi-Yanaga – volume: 348 start-page: 791 year: 2003 ident: 10.1016/j.bcp.2014.03.006_bib0150 article-title: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH publication-title: N Engl J Med doi: 10.1056/NEJMoa025283 contributor: fullname: Sieber – volume: 274 start-page: 1672 year: 1996 ident: 10.1016/j.bcp.2014.03.006_bib0020 article-title: Cancer cell cycles publication-title: Science doi: 10.1126/science.274.5293.1672 contributor: fullname: Sherr – volume: 18 start-page: 3004 year: 1999 ident: 10.1016/j.bcp.2014.03.006_bib0035 article-title: MYC oncogenes and human neoplastic disease publication-title: Oncogene doi: 10.1038/sj.onc.1202746 contributor: fullname: Nesbit – volume: 9 start-page: 245 year: 2010 ident: 10.1016/j.bcp.2014.03.006_bib0130 article-title: Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway publication-title: Mol Cancer doi: 10.1186/1476-4598-9-245 contributor: fullname: Yoshihara – volume: 20 start-page: 581 year: 2008 ident: 10.1016/j.bcp.2014.03.006_bib0090 article-title: GSK-3β regulates cyclin D1 expression: a new target for chemotherapy publication-title: Cell Signal doi: 10.1016/j.cellsig.2007.10.018 contributor: fullname: Takahashi-Yanaga – volume: 21 start-page: 1307 year: 2006 ident: 10.1016/j.bcp.2014.03.006_bib0125 article-title: Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines publication-title: J Bone Miner Res doi: 10.1359/jbmr.060512 contributor: fullname: Matsuzaki – volume: 281 start-page: 38489 year: 2006 ident: 10.1016/j.bcp.2014.03.006_bib0120 article-title: Involvement of GSK-3β and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells publication-title: J Biol Chem doi: 10.1074/jbc.M605205200 contributor: fullname: Takahashi-Yanaga – volume: 20 start-page: 781 year: 2004 ident: 10.1016/j.bcp.2014.03.006_bib0050 article-title: The Wnt signaling pathway in development and disease publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev.cellbio.20.010403.113126 contributor: fullname: Logan – volume: 3 start-page: 267 year: 2006 ident: 10.1016/j.bcp.2014.03.006_bib0065 article-title: Mechanisms of disease: from stem cells to colorectal cancer publication-title: Nat Clin Pract Gastroenterol Hepatol doi: 10.1038/ncpgasthep0473 contributor: fullname: McDonald – volume: 96 start-page: 13300 year: 1999 ident: 10.1016/j.bcp.2014.03.006_bib0185 article-title: Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.23.13300 contributor: fullname: Klungland – volume: 278 start-page: 38121 year: 2003 ident: 10.1016/j.bcp.2014.03.006_bib0180 article-title: Mutator phenotype of MUTYH-null mouse embryonic stem cells publication-title: J Biol Chem doi: 10.1074/jbc.C300316200 contributor: fullname: Hirano – volume: 83 start-page: 47 year: 2012 ident: 10.1016/j.bcp.2014.03.006_bib0135 article-title: DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.10.001 contributor: fullname: Jingushi – volume: 67 start-page: 6599 year: 2007 ident: 10.1016/j.bcp.2014.03.006_bib0155 article-title: MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4802 contributor: fullname: Sakamoto – volume: 342 start-page: 1946 year: 2000 ident: 10.1016/j.bcp.2014.03.006_bib0170 article-title: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis publication-title: N Engl J Med doi: 10.1056/NEJM200006293422603 contributor: fullname: Steinbach – volume: 30 start-page: 227 year: 2002 ident: 10.1016/j.bcp.2014.03.006_bib0140 article-title: Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors publication-title: Nat Genet doi: 10.1038/ng828 contributor: fullname: Al-Tassan – volume: 296 start-page: 1644 year: 2002 ident: 10.1016/j.bcp.2014.03.006_bib0010 article-title: The promise and perils of Wnt signaling through β-catenin publication-title: Science doi: 10.1126/science.1071549 contributor: fullname: Moon – volume: 52 start-page: 1 year: 1998 ident: 10.1016/j.bcp.2014.03.006_bib0030 article-title: Cyclin D1 in breast cancer publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006103831990 contributor: fullname: Barnes – volume: 73 start-page: 1318 year: 2007 ident: 10.1016/j.bcp.2014.03.006_bib0190 article-title: Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.12.033 contributor: fullname: Sakoguchi-Okada – volume: 275 start-page: 1787 year: 1997 ident: 10.1016/j.bcp.2014.03.006_bib0055 article-title: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC publication-title: Science doi: 10.1126/science.275.5307.1787 contributor: fullname: Morin – volume: 61 start-page: 226 year: 2001 ident: 10.1016/j.bcp.2014.03.006_bib0040 article-title: Correlation of β-catenin and cyclin D1 expression in colon cancers publication-title: Oncology doi: 10.1159/000055379 contributor: fullname: Utsunomiya |
SSID | ssj0006861 |
Score | 2.3441224 |
Snippet | We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 340 |
SubjectTerms | Animals Antineoplastic Agents, Phytogenic - therapeutic use Cyclin D1 - genetics Cyclin D1 - metabolism DIF-1 DNA Glycosylases - genetics DNA Glycosylases - metabolism Egr-1 Gene Expression Regulation, Neoplastic - drug effects Glycogen Synthase Kinase 3 - genetics Glycogen Synthase Kinase 3 - metabolism Glycogen Synthase Kinase 3 beta GSK-3β Hexanones - therapeutic use Mice Mice, Knockout Neoplasms, Experimental - drug therapy Neoplasms, Experimental - metabolism Oxidative Stress Phosphorylation TCF7L2 Transcription Factor 7-Like 2 Protein - genetics Transcription Factor 7-Like 2 Protein - metabolism Wnt/β-catenin signaling pathway |
Title | DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice |
URI | https://dx.doi.org/10.1016/j.bcp.2014.03.006 https://www.ncbi.nlm.nih.gov/pubmed/24670930 https://search.proquest.com/docview/1521329645 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcoALgvIqj8pIqAdU08SOvcmx2rJsKVSV2Eq9WY4f3SA1WW2yFXvhxC_ih_CbmMmDFYdy4JBD4iS28k1mxpqZbwh5A_6atD4ENjIyZUnscmbSkLGQBilNzlWmsMD585maXiQfL-XlFhkPtTCYVtnr_k6nt9q6v3LYf83DRVFgjW-kYCYOWwTsMY-020i2BTL97vsmzUOlqu-apxjePUQ22xyv3CJlZZx0PKfqNtt0m-_Z2qDJA3K_dx7pUbe-h2TLlzvk7njo2bZD9s87Jur1AZ1tCqvqA7pPzzcc1etH5MfxyYTFtCjnRV40NW1W19WSXsGevJnDVXpT3FR0ibSuYNroYl7VcCzXXeIcrQL98OWUiV8_qSkd9d_6bNqyxiG7xnJLehy3g7PxZPSJ4zstCtiStr136DUoqMfkYvJ-Np6yviEDs0KKhglhechc5sUoB9eGGy5DzHlmwccxKs9T54yNnPUKf-vIJBbGfcQzlXE3Eol4QrbLqvTPCAUda6VLjQtJBjvE1AQXeem6MGmayV3ydoBCLzreDT0kpH3VgJtG3HQkNOC2S5IBLP2X8GiwC_967PUArAacMFJiSl-tao1OjcCANKzjaYf4n1XwBCnvRPT8_yZ9Qe7hWZdt9pJsN8uVfwV-TZPvtYK7R-4cnZxOz34D8Gr2Sw |
link.rule.ids | 315,783,787,4511,24130,27938,27939,45601,45695 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECVS55Beijbd0pUFihyKCJFIkRaPgVPXrh0jQB0gN4LiEqtAJEOSg_reL-qH9Js61JKgh_TQgy4cUCT0qJlHzIbQR-BrTFvngqFiSRBHJg1U4kTgEseYSgkX3Cc4ny345CL-eskud9Coz4XxYZWd7m91eqOtu5Hj7mser7PM5_iGHFYicEXwPeb5A7QLbECwAdo9mc4mi1uFzBPeNc7jgZ_QOzebMK9U-6qVUdyWOuX3maf76GdjhsaP0aOOP-KTdotP0I7N99HeqG_bto8Oz9ti1NsjvLzLraqO8CE-vytTvX2Kfp5Ox0GEs3yVpVld4XpzXZT4Cq7l9QpG8U12U-DSV3YF64bXq6KCp9y2sXO4cPjLt1lAf__CKjfY_ugCavPKi_TWZ1zi06gRLkfj4Zz4d2p_xkrctN_B16CjnqGL8eflaBJ0PRkCTRmtA0o1ccIIS4cpsBuiCHMRIUIDzVE8TRNjlA6Nttz_2aGKNchtSAQXxAxpTJ-jQV7k9iXCoGY1M4kyLhZwSUyUM6FlpvWUJoIdoE89FHLdlt6QfUzadwm4SY-bDKkE3A5Q3IMl_zo_EkzDv6Z96IGVgJN3lqjcFptKel5DvU8a9vGiRfx2FyT2Ve9o-Or_Fn2P9ibLs7mcTxez1-ihl7TBZ2_QoC439i3QnDp91x3jP4vt-Qo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DIF-1+inhibits+tumor+growth+in+vivo+reducing+phosphorylation+of+GSK-3%CE%B2+and+expressions+of+cyclin+D1+and+TCF7L2+in+cancer+model+mice&rft.jtitle=Biochemical+pharmacology&rft.au=Takahashi-Yanaga%2C+Fumi&rft.au=Yoshihara%2C+Tatsuya&rft.au=Jingushi%2C+Kentaro&rft.au=Igawa%2C+Kazuhiro&rft.date=2014-06-01&rft.eissn=1873-2968&rft.volume=89&rft.issue=3&rft.spage=340&rft.epage=348&rft_id=info:doi/10.1016%2Fj.bcp.2014.03.006&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2952&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2952&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2952&client=summon |